semaglutide and heart problems Cuts Risk Beyond Weight Loss: Study FDA Approves First Treatment to

Yan, F., Li, K., Xing, W., Dong, M., Yi, M., & Zhang, H

Retrieved from Boukssim, S., & Chbicheb, S

Certain Medical Conditions People with a history of pancreatitis, severe gastrointestinal disease, or other relevant health conditions should carefully review potential risks with a licensed clinician before considering treatment

A 2025 network meta-analysis published in Metabolism , covering 22 randomized controlled trials and over 2200 participants, confirmed that tirzepatide and semaglutide were among the least effective GLP-1 agents for preserving lean mass, the very agents showing the greatest weight loss

The Obesity Medicine Association adds that while these medications can help lower the barrier to behavior change, healthy habits are still essential for long-term success

A: To maintain stability, Retatrutide should be stored in a cool, dry place, typically at -20C for long-term preservation, protected from light.